KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

NORDEA INVESTMENT MANAGEMENT AB's Holding History (CIK: 0001218210)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 110,682 Value ($000) $4,539 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 131,074 Value ($000) $5,016 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 130,160 Value ($000) $3,582 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 128,050 Value ($000) $2,871 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 194,883 Value ($000) $3,818 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 186,626 Value ($000) $4,709 Avg Close $24.36 Range $17.38 - $27.92

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	110,682	$4,539	$40.11	$35.20 - $44.42
Q3 2025	131,074	$5,016	$32.49	$26.27 - $39.00
Q2 2025	130,160	$3,582	$25.46	$18.25 - $30.69
Q1 2025	128,050	$2,871	$20.58	$17.82 - $24.31
Q4 2024	194,883	$3,818	$22.82	$19.47 - $28.15
Q3 2024	186,626	$4,709	$24.36	$17.38 - $27.92